Director/PDMR Shareholding

1.

Name of the issuer

Consort Medical plc

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

I - DTR 3.1.2

3.

Name of person discharging managerial

responsibilities/director

Iain Ward

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

The Notification is in respect of the Holdings of the persons referred to in 3 above.

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

N/A

8.

State the nature of the transaction

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

11.

Number of shares, debentures or financial

instruments relating to shares disposed

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

13.

Price per share or value of transaction

N/A

14.

Date and place of transaction

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

N/A

16.

Date issuer informed of transaction

N/A

17.

Date of grant

14 July 2014

18.

Period during which or date on which exercisable

14 July 2017 to 23 August 2017 provided the applicable performance criteria have been satisfied.

19.

Total amount paid (if any) for grant of the option

NIL

20.

Description of shares or debentures involved (class and number)

Grant of Performance Shares under the Consort Medical 2005 Long Term Incentive Plan in respect of ordinary 10 pence shares as indicated in the table below:

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

£9.506

22.

Total number of shares or debentures over which options held following notification

Please see table below:

23.

Any additional information

None

24.

Name of contact and telephone number for queries

Richard Cotton- 01442 867920

Name of authorised official of issuer responsible for making notification - Richard Cotton

Date of notification: 16 July 2014

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.